Robert D. Schreiber
Affiliations: | Biology & Biomedical Sciences (Immunology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Immunology, Pathology, Microbiology BiologyGoogle:
"Robert Schreiber"Bio:
https://source.wustl.edu/2008/08/roediger-schreiber-to-receive-faculty-achievement-awards-2/
https://cdn-pubs.acs.org/doi/pdf/10.1021/bi00768a004
Parents
Sign in to add mentor| Robert Warren Noble | grad student | 1973 | SUNY Buffalo (Chemistry Tree) | |
| (Partial Resolution of Antibody Heterogeneity in Anti-Protein Sera: Immunochemical and Biochemical Studies on Antibody Populations Directed Toward a Single Antigenic Determinant on Human Hemoglobin.) | ||||
Children
Sign in to add trainee| Michael A. Farrar | grad student | 1993 | Washington University in St. Louis, School of Medicine |
| Vijay Shankaran | grad student | 2001 | Washington University |
| Gregory H. Schreiber | grad student | 2002 | Washington University |
| Allen T. Bruce | grad student | 2004 | Washington University |
| Gavin P. Dunn | grad student | 2006 | Washington University |
| Catherine M. Koebel | grad student | 2007 | Washington University |
| Mark S. Diamond | grad student | 2010 | Washington University |
| Matthew D. Vesely | grad student | 2013 | Washington University |
| Siu K. Lam | grad student | 2014 | Washington University |
| Charles G. Rickert | grad student | 2014 | Washington University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Achilefu S, Egbulefu C, Black K, et al. (2024) Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapse. Research Square |
| Ferris ST, Ohara RA, Ou F, et al. (2022) cDC1 vaccines drive tumor rejection by direct presentation independently of host cDC1. Cancer Immunology Research |
| Ferris ST, Durai V, Wu R, et al. (2020) cDC1 prime and are licensed by CD4 T cells to induce anti-tumour immunity. Nature |
| Molgora M, Esaulova E, Vermi W, et al. (2020) TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy. Cell |
| Johanns TM, Miller CA, Liu CJ, et al. (2019) Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma. Oncoimmunology. 8: e1561106 |
| Theisen DJ, Davidson JT, Briseño CG, et al. (2018) WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science (New York, N.Y.). 362: 694-699 |
| Gubin MM, Esaulova E, Ward JP, et al. (2018) High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy. Cell |
| Shankaran V, Ikeda H, Bruce AT, et al. (2018) Pillars Article: IFNγ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. . 2001. 410: 1107-1111. Journal of Immunology (Baltimore, Md. : 1950). 201: 827-831 |
| Alspach E, Lussier DM, Schreiber RD. (2018) Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity. Cold Spring Harbor Perspectives in Biology |
| Zolkind P, Przybylski D, Marjanovic N, et al. (2018) Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget. 9: 4109-4119 |